ES443982A1 - Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos. - Google Patents

Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos.

Info

Publication number
ES443982A1
ES443982A1 ES443982A ES443982A ES443982A1 ES 443982 A1 ES443982 A1 ES 443982A1 ES 443982 A ES443982 A ES 443982A ES 443982 A ES443982 A ES 443982A ES 443982 A1 ES443982 A1 ES 443982A1
Authority
ES
Spain
Prior art keywords
gamma globulins
gamma
process reducing
anticomplementary activity
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES443982A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RATIOPHARMA ANSTALT
Original Assignee
RATIOPHARMA ANSTALT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RATIOPHARMA ANSTALT filed Critical RATIOPHARMA ANSTALT
Publication of ES443982A1 publication Critical patent/ES443982A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES443982A 1975-01-02 1975-12-30 Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos. Expired ES443982A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (1)

Publication Number Publication Date
ES443982A1 true ES443982A1 (es) 1977-07-16

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
ES443982A Expired ES443982A1 (es) 1975-01-02 1975-12-30 Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos.

Country Status (20)

Country Link
JP (1) JPS5512001B2 (OSRAM)
AT (1) AT344883B (OSRAM)
AU (1) AU505416B2 (OSRAM)
BE (1) BE837211A (OSRAM)
CA (1) CA1058075A (OSRAM)
DD (1) DD121875A5 (OSRAM)
DE (1) DE2500076C3 (OSRAM)
DK (1) DK144679C (OSRAM)
EG (1) EG11987A (OSRAM)
ES (1) ES443982A1 (OSRAM)
FR (1) FR2296429A1 (OSRAM)
GB (1) GB1495159A (OSRAM)
IE (1) IE43449B1 (OSRAM)
IL (1) IL48766A (OSRAM)
IN (1) IN143525B (OSRAM)
NL (1) NL179824C (OSRAM)
PL (1) PL99599B1 (OSRAM)
SE (1) SE437470B (OSRAM)
SU (1) SU576898A3 (OSRAM)
ZA (1) ZA758050B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
ATE19735T1 (de) * 1982-02-08 1986-05-15 Schweiz Serum & Impfinst Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung.
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
CN117903302A (zh) 2005-11-30 2024-04-19 Abbvie 公司 抗-Aβ球聚体抗体，其相关产品，生产所述抗体的方法，所述抗体的应用以及使用方法
AU2006320392B2 (en) 2005-11-30 2013-01-17 AbbVie Deutschland GmbH & Co. KG Monoclonal antibodies against amyloid beta protein and uses thereof
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
MX360403B (es) 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
CN103298833B (zh) 2010-08-14 2015-12-16 Abbvie公司 β淀粉样蛋白结合蛋白

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (OSRAM) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (OSRAM) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
DK584375A (da) 1976-07-03
SE437470B (sv) 1985-03-04
GB1495159A (en) 1977-12-14
AT344883B (de) 1978-08-10
BE837211A (fr) 1976-06-30
IN143525B (OSRAM) 1977-12-17
ATA981675A (de) 1977-12-15
DE2500076B2 (de) 1979-02-22
IL48766A (en) 1979-11-30
NL179824B (nl) 1986-06-16
JPS5512001B2 (en) 1980-03-29
DE2500076C3 (de) 1982-11-18
JPS5191321A (en) 1976-08-10
PL99599B1 (pl) 1978-07-31
AU505416B2 (en) 1979-11-22
FR2296429A1 (fr) 1976-07-30
IE43449L (en) 1976-07-02
EG11987A (en) 1981-12-31
IE43449B1 (en) 1981-02-25
DE2500076A1 (de) 1976-07-08
DD121875A5 (OSRAM) 1976-09-05
SE7514388L (sv) 1976-07-05
NL179824C (nl) 1986-11-17
DK144679C (da) 1982-10-11
IL48766A0 (en) 1976-02-29
DK144679B (da) 1982-05-10
SU576898A3 (ru) 1977-10-15
CA1058075A (en) 1979-07-10
NL7514627A (nl) 1976-07-06
ZA758050B (en) 1976-12-29
FR2296429B1 (OSRAM) 1978-12-01
AU8792175A (en) 1977-07-14

Similar Documents

Publication Publication Date Title
ES443982A1 (es) Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos.
NO820226L (no) Fremgangsmaate for fremstilling av alkaliopploeselig cellulosederivat
ES402176A1 (es) Un procedimiento para preparar un complejo de sal de insu- lina y protamina.
ES395315A1 (es) Procedimiento para la separacion de proteinas a partir de pescado.
NL7613185A (nl) Werkwijze ter bereiding van cellulose-oplossing, alsmede onder toepassing daarvan vervaardigde voortbrengselen.
AT274729B (de) Verfahren zur Aldehydbehandlung (Formalisierung) von Zellulose, Zelluloseestern und Stärke
DK135537B (da) Fremgangsmåde til fremstilling af et antiviralt complex af polykvaternære ammoniumforbindelser af eventuelt modificerede dobbeltstrengende ribonucleinsyrer af naturlig oprindelse.
ES325333A1 (es) Procedimiento para preparar composiciones acuosas.
IT1040118B (it) Ricupero mediante coagulazione di resine di polisolfoni dalo ro soluzioni
GB1062434A (en) Process for isolating -antitrypsin
NL7504695A (nl) Prostaanzuurderivaten en werkwijze voor de be- reiding daarvan.
NL166711C (nl) Werkwijze ter bereiding van mengsels op basis van voorpolymeren uit n,n'-bisimiden van maleinezuur en biprimaire diaminen.
ES404001A1 (es) Procedimiento para la obtencion de compelejos de dos compo-nentes.
SE7504794L (sv) Forfarande for framstellning av cyanursyra
GB1352613A (en) Stabilized agar product and method for its stabilization
ES423262A1 (es) Un procedimiento para reducir la cantidad de acidos nuclei-cos en un material proteinaceo.
CH552635A (de) Verfahren zur herstellung von hydrophoben staerkederivaten, nach diesem verfahren hergestellte staerkederivate und deren verwendung.
GB1011013A (en) Disaggregated gamma globulin and process for preparing it
FR2041806A7 (en) Herbicidal haloacrylic acids
GB994621A (en) New derivatives of heparin and processes for their preparation
CH554350A (de) Verfahren zur herstellung von n-substituierten, symmetrischen dihydrotriazin-derivaten.
ES428937A1 (es) Un procedimiento mejorado para la purificacion de acido sulfurico acuoso.
ES445395A1 (es) Un procedimiento de preparacion de 1-o-acetoxibenzoil-4-hi- droxi-l'prolina y 1-o-acetoxibenzoil-l-prolina.
SU704621A1 (ru) Способ лечени нарушений функционального состо ни печени при синдроме массивных трансфузий крови
SU489763A1 (ru) Поливинилхлоридна композици